Importantly, Kv10.1 expression correlates with poor prognosis in fibrosarcoma, ovarian carcinoma, acute myeloid leukemia (AML) and colon, head and neck cancer (Pardo and Stühmer 2014). Here, KCNH1 is linked to acute myeloid leukemia.